PLx Pharma Inc. is a commercial-stage drug delivery technology company headquartered in Sparta, New Jersey, that specializes in improving the absorption of active pharmaceutical ingredients via its patented PLxGuard™ technology. The company’s flagship product, VAZALORE, is an FDA-approved liquid-filled aspirin capsule available in 81 mg and 325 mg doses. Prior to recent operational shifts, the company maintained distribution across 30,000 retail and e-commerce sites nationwide. It is a publicly traded entity (NASDAQ: PLXP).
